Understanding statin non-adherence: knowing which perceptions and experiences matter to different patients H Wouters, L Van Dijk, HCJ Geers, NA Winters, ECG Van Geffen, ... PloS one 11 (1), e0146272, 2016 | 67 | 2016 |
mHealth intervention to support asthma self-management in adolescents: the ADAPT study RC Kosse, ML Bouvy, TW De Vries, AA Kaptein, HCJ Geers, L Van Dijk, ... Patient preference and adherence, 571-577, 2017 | 54 | 2017 |
Estimates of statin discontinuation rates are influenced by exposure and outcome definitions HCJ Geers, ML Bouvy, ER Heerdink Annals of Pharmacotherapy 45 (5), 576-581, 2011 | 25 | 2011 |
Do the benefits of statins outweigh their drawbacks? Assessing patients' trade-off preferences with conjoint analysis H Wouters, L Van Dijk, ECG Van Geffen, HCJ Geers, PC Souverein, ... International journal of cardiology 176 (3), 1220-1222, 2014 | 8 | 2014 |
Minimale interventie in een cohort van chronische benzodiazepinegebruikers H Geers, B Arents, ML Bouvy Pharmaceutisch Weekblad 3, 62-66, 2009 | 5 | 2009 |
Measuring and predicting medication adherence using dispensing data and patient beliefs HCJ Geers Utrecht University, 2012 | 4 | 2012 |
Influence of therapeutic complexity on medication adherence in the Netherlands HCJ Geers, ML Bouvy, ER Heerdink Archives of internal medicine 171 (9), 864-865, 2011 | 4 | 2011 |
De standaard en de praktijk. Gebruik van inhalatiecorticosteroiden bij chronisch astma (Standard and practice. Use of inhaled corticosteroids in chronic asthma) H Geers, HM Pot, WCK Overmars-vander Weij, C Gerrits, H Buurma Pharm Weekbl 136, 266-70, 2001 | 4 | 2001 |
Effects telephone counselling intervention by pharmacist on beliefs about medicines for patients starting treatment: Results of an interim analysis of a cluster randomized … MJ Kooy, ER Heerdink, EC Van Geffen, HC Geers, ML Bouvy International Journal of Clinical Pharmacy 35 (5), 896-897, 2013 | 1 | 2013 |
SYNTHESE EN EVALUATIE VAN N-METHYL-1, 2, 3, 6-TETRAHYDROPYRIDINES: STIPENDIAFONDS KNMP HCJ Geers Pharmaceutisch weekblad 129 (22-23), 582-586, 1994 | 1 | 1994 |
Experience and possible applications for a creatinine Point of Care Test (POCT) in community pharmacy practice L van der Werf, HCJ Geers INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 41 (2), 600-600, 2019 | | 2019 |
De invloed van SGLT-2-remmers op de nierfunctie en cardiovasculaire risico’s H Geers Nederlands Platform voor Farmaceutisch Onderzoek, 2018 | | 2018 |
Het gebruik van thiazidediuretica bij een zeer lage glomerulaire filtratiesnelheid H Geers Nederlands Platform voor Farmaceutisch Onderzoek, 2018 | | 2018 |
Difference in Persistence Rates between Responders and Non-Responders to Mailed Questionnaires HCJ Geers, ER Heerdink, ML Bouvy PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 21, 327-327, 2012 | | 2012 |
Therapeutic Complexity Has Limited Influence on Adherence in the Netherlands HC Geers, ML Bouvy, ER Heerdink PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 20, S136-S137, 2011 | | 2011 |
Discontinuation Rates of Statins Vary If Different Calculation Methods Are Used HCJ Geers, ML Bouvy, R Heerdink PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 19, S34-S34, 2010 | | 2010 |
Does short-term non-compliance predict long term non-compliance in ambulatory patients? HCJ Geers, AACG Egberts, EER Heerdink, Blaey de, Kees CJ PHARMACY WORLD & SCIENCE 29 (5), 441-441, 2007 | | 2007 |
Early identification of long-term poor adherence in ambulatory patients HCJ Geers, CJ de Blaey, ACG Egberts, ML Bouvy, ER Heerdink ANNALS OF PHARMACOTHERAPY 40 (12), 2277-2278, 2006 | | 2006 |
Early identification of long term poor compliance in ambulatory patients using a multivariate risk score model HCJ Geers, CJ de Blaey, ACG Egberts, ER Heerdink PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 15, S160-S160, 2006 | | 2006 |
Descripción de# 49 SGLT2 remmers bij hartfalen, een diabetes middel bij hartfalen? H Geers | | |